Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,307.90
-6.15
(-0.19%)
Nikkei
38,946.93
-122.75
(-0.31%)
Hang Seng
19,220.62
-415.60
(-2.12%)
FTSE 100
8,416.45
-7.75
(-0.09%)
Bitcoin USD
69,542.16
+367.57
(+0.53%)
CMC Crypto 200
1,515.10
+26.56
(+1.78%)
Standard BioTools Inc. (LAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5800
0.0000
(0.00%)
At close: 04:00PM EDT
2.5800
0.00
(0.00%)
After hours:
04:01PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
126,761
106,340
97,948
130,581
138,144
Cost of revenue
64,404
55,890
60,897
61,208
54,818
Gross profit
62,357
50,450
37,051
69,373
83,326
Operating expenses
Research development
35,499
25,948
37,382
37,944
36,461
Selling general and administrative
113,189
87,541
102,285
98,888
97,901
Total operating expenses
148,688
113,489
139,667
136,832
134,362
Operating income or loss
-86,331
-63,039
-102,616
-67,459
-51,036
Interest expense
-
4,567
4,331
3,823
3,572
Total other income/expenses net
-3,857
-6,598
-85,981
7,622
507
Income before tax
-89,653
-74,204
-192,928
-63,660
-54,101
Income tax expense
317
452
-2,830
-4,423
-1,081
Income from continuing operations
-89,970
-74,656
-190,098
-59,237
-53,020
Net income
-89,970
-74,656
-190,098
-59,237
-53,020
Net income available to common shareholders
-135,984
-74,656
-190,098
-59,237
-53,020
Basic EPS
-0.95
-0.94
-2.43
-0.78
-0.74
Diluted EPS
-0.95
-0.94
-2.43
-0.78
-0.74
Basic average shares
79,087
79,160
78,305
75,786
72,044
Diluted average shares
79,087
79,160
78,305
75,786
72,044
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.